Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2007-005462-12-SE
EUCTR2007-005462-12-SEActive, not recruitingNot Applicable

A prospective, randomized, masked and controlled trial of intravitreal ranibizumab (Lucentis®) combined with transpupillary thermotherapy (TTT) in patients with neovascular age-related macular degeneration (AMD)

St. Eriks Eye Hospital0 sites100 target enrollmentStarted: October 15, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
100
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •Patients with neovascular AMD age 50 years or older who have a visual acuity of 0.1 (20/200) or better
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •Patients aged < 50 years
  • •BCVA < 0.1
  • •Subfoveal fibrosis or atrophy
  • •Previous treatment for neovascular AMD
  • •CNV of other causes that AMD
  • •Intraocular surgery within 3 months
  • •Untreated glaucoma
  • •Inflammation or infection in study eye
  • •Retinal vascular disease of any origin

Investigators

Sponsor
St. Eriks Eye Hospital

Similar Trials

Active, not recruiting
Not Applicable
A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin®) for central retinal vein occlusion (CRVO).Central retinal vein occlusion (CRVO) is a sight-threatening ocular condition without efficient treatment.
EUCTR2008-006265-93-SESt Eriks Eye Hospital60
Active, not recruiting
Not Applicable
A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin) versus verteporfin photodynamic therapy (PDT) in patients with neovascular age-related macular degeneration.
EUCTR2006-001200-36-SESt. Eriks Eye Hospital100
Recruiting
Not Applicable
A prospective clinical trial for the treatment of keratoconjunctivitis caused by microsporidia.
CTRI/2011/11/002132Hyderabad Eye Research Foundation72
Active, not recruiting
Not Applicable
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures. - TIMELI 001nilateral, uncomplicated primary inguinal hernia repairClassification code 10022020
EUCTR2005-002741-39-DKniversità di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggiore Policlinico, Padiglione328
Active, not recruiting
Phase 1
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures.
EUCTR2005-002741-39-ESPr Giampiero CAMPANELLI - Ospedale Maggiore Policlinico, Padiglione Beretta Est328